País: Irlanda
Idioma: anglès
Font: HPRA (Health Products Regulatory Authority)
TRAMADOL HYDROCHLORIDE, PARACETAMOL
PCO Manufacturing
N02AJ13
TRAMADOL HYDROCHLORIDE, PARACETAMOL
37.5/325 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
opiods in combination with non-opiod analgesics
Authorised
2011-08-19
_ _ _ _ CONTAINS PARACETAMOL PACKAGE LEAFLET: INFORMATION FOR THE USER IXPRIM ® 37.5MG/325MG, FILM-COATED TABLETS Tramadol hydrochloride/Paracetamol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. – Keep this leaflet. You may need to read it again. – If you have any further questions, please ask your doctor or pharmacist. – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet (see section 4). WHAT IS IN THIS LEAFLET: 1. What IXPRIM is and what it is used for 2. What you need to know before you take IXPRIM 3. How to take IXPRIM 4. Possible side effects 5. How to store IXPRIM 6. Contents of the pack and other information 1. WHAT IXPRIM IS AND WHAT IT IS USED FOR IXPRIM is a combination of two analgesics, tramadol and paracetamol, which act together to relieve your pain. IXPRIM is intended for use in the treatment of moderate to severe pain when your doctor recommends that a combination of tramadol and paracetamol is needed. IXPRIM should only be taken by adults and adolescents over 12 yea Llegiu el document complet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ixprim 37.5 mg/325 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains 37.5 mg tramadol hydrochloride and 325 mg paracetamol. Excipient with known effect: lactose For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet _Product imported from the United Kingdom and Spain:_ Pale yellow film-coated tablet, marked with the manufacturers logo on one side and ‘T5’ on the other side. 4 CLINICAL PARTICULARS As per PA1189/005/001 5 PHARMACOLOGICAL PROPERTIES As per PA1189/005/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS _Tablet core:_ powdered cellulose pregelatinised starch sodium starch glycolate (Type A) maize starch magnesium stearate _Film-coating:_ hypromellose lactose monohydrate titanium dioxide (E171) macrogol 6000 yellow iron oxide (E172) propylene glycol talc 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 26/01/2015_ _CRN 2156940_ _page number: 1_ The shelf-life expiry date of this product is the date shown on the blister foil and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE This medicinal product does not require any special storage conditions. 6.5 NATURE AND CONTENTS OF CONTAINER Blister packs of 60 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Unit 10 Ashbourne Business Park, Rath, Ashbourne Co. Meath Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0465/282/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION The date of fi Llegiu el document complet